A Study to Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β)-Thalassemia
Clinical trial NCT03342404 · COMPLETED
Trial details
- NCT number
- NCT03342404
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-05
- Primary completion
- 2022-11-28
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.